Dr. Michael Buschle
More than 25 years of experience in biotech and pharma. PhD from the University of London. Research at St. Jude’s Children’s Research Hospital, Boehringer Ingelheim-owned Institute of Molecular Pathology, Vienna. Industrial experience: Boehringer Ingelheim, Co-founder of Intercell with successful IPO, Chief Scientific Officer of Glenmark Pharmaceuticals.